LBG provides a range of nonclinical services to support and advance programs to achieve product development objectives from discovery through regulatory submission. We provide advisory services for full scope nonclinical product development, strategic business development, and due diligence of therapeutics (small and large molecule), vaccines, medical devices, and diagnostics. LBG brings a broad range of internal subject matter expertise in DMPK, toxicology, and in vivo / in vitro modeling. Utilizing our unique combination of program management and technical/thought leadership, we guide our clients through the product development continuum to manage risk and mitigate delays. We carefully manage and select CRO partners to ensure high quality, reliable, and reproducible data. Our consultants integrate seamlessly with our clients’ [team] to ameliorate internal resource strain, increase programmatic efficiency, and reduce capital burn rates.
LBG Nonclinical Consulting Services Include:
- Nonclinical Project Management & Study Execution
- Nonclinical Regulatory Strategy Consulting
- Nonclinical Vendor and CRO Selection & Management
- Bioanalytical Program Development & Management
- Thought / Technical Leadership